Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression

Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) has been described as an inflammatory disorder with an eosinophilic component with etiopathogenesis that is still unknown. Sixteen intestinal samples from two veterinary diagnostic services (2014–2017) were included in the study. A...

Full description

Bibliographic Details
Main Authors: Néstor Porras, Agustín Rebollada-Merino, Fernando Rodríguez-Franco, Andrés Calvo-Ibbitson, Antonio Rodríguez-Bertos
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/9/6/291
_version_ 1811153724927639552
author Néstor Porras
Agustín Rebollada-Merino
Fernando Rodríguez-Franco
Andrés Calvo-Ibbitson
Antonio Rodríguez-Bertos
author_facet Néstor Porras
Agustín Rebollada-Merino
Fernando Rodríguez-Franco
Andrés Calvo-Ibbitson
Antonio Rodríguez-Bertos
author_sort Néstor Porras
collection DOAJ
description Feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) has been described as an inflammatory disorder with an eosinophilic component with etiopathogenesis that is still unknown. Sixteen intestinal samples from two veterinary diagnostic services (2014–2017) were included in the study. A histopathological criterion classified the cases into three grades (mild, moderate, and severe) according to the distribution of the lesions and the course. An immunohistochemical study of collagen I, collagen III, fibronectin, and transforming growth factor β1 (TGF-β1) was performed in each case. An immunohistochemical study of mild grades shows greater collagen III immunoexpression, compared to collagen I and fibronectin, which suggests an “early” stage of fibrosis. In more intense grades, an increased immunoexpression of collagen I, compared to collagen III, suggests a “late” stage of fibrosis. Otherwise, the highest expression of TGF-β1 was observed in the moderate phase, due to the high proliferation of reactive fibroblast and intense inflammation. The results suggest that the inflammatory infiltrate is the trigger for the elevation in TGF-β1, altering the collagen type III:I ratio. In conclusion, immunohistochemical studies can be a very useful method in diagnosing cases of FGESF of mild grades and could help to apply a differential diagnosis regarding feline eosinophilic chronic enteritis (CEE) in the context of inflammatory bowel disease (IBD).
first_indexed 2024-03-09T22:16:30Z
format Article
id doaj.art-a7cd0157192d496793eecff66101247c
institution Directory Open Access Journal
issn 2306-7381
language English
last_indexed 2024-03-09T22:16:30Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj.art-a7cd0157192d496793eecff66101247c2023-11-23T19:23:28ZengMDPI AGVeterinary Sciences2306-73812022-06-019629110.3390/vetsci9060291Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 ImmunoexpressionNéstor Porras0Agustín Rebollada-Merino1Fernando Rodríguez-Franco2Andrés Calvo-Ibbitson3Antonio Rodríguez-Bertos4VISAVET Health Surveillance Centre, Complutense University of Madrid, 28040 Madrid, SpainVISAVET Health Surveillance Centre, Complutense University of Madrid, 28040 Madrid, SpainDepartment of Internal Medicine and Animal Surgery, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, SpainVetPatólogos, Av. Isabel de Farnesio, 27, 28660 Boadilla del Monte, SpainVISAVET Health Surveillance Centre, Complutense University of Madrid, 28040 Madrid, SpainFeline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) has been described as an inflammatory disorder with an eosinophilic component with etiopathogenesis that is still unknown. Sixteen intestinal samples from two veterinary diagnostic services (2014–2017) were included in the study. A histopathological criterion classified the cases into three grades (mild, moderate, and severe) according to the distribution of the lesions and the course. An immunohistochemical study of collagen I, collagen III, fibronectin, and transforming growth factor β1 (TGF-β1) was performed in each case. An immunohistochemical study of mild grades shows greater collagen III immunoexpression, compared to collagen I and fibronectin, which suggests an “early” stage of fibrosis. In more intense grades, an increased immunoexpression of collagen I, compared to collagen III, suggests a “late” stage of fibrosis. Otherwise, the highest expression of TGF-β1 was observed in the moderate phase, due to the high proliferation of reactive fibroblast and intense inflammation. The results suggest that the inflammatory infiltrate is the trigger for the elevation in TGF-β1, altering the collagen type III:I ratio. In conclusion, immunohistochemical studies can be a very useful method in diagnosing cases of FGESF of mild grades and could help to apply a differential diagnosis regarding feline eosinophilic chronic enteritis (CEE) in the context of inflammatory bowel disease (IBD).https://www.mdpi.com/2306-7381/9/6/291collagenfeline gastrointestinal eosinophilic sclerosing fibroplasiafibronectinintestinal fibrosisimmunohistochemistryTGF-β1
spellingShingle Néstor Porras
Agustín Rebollada-Merino
Fernando Rodríguez-Franco
Andrés Calvo-Ibbitson
Antonio Rodríguez-Bertos
Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
Veterinary Sciences
collagen
feline gastrointestinal eosinophilic sclerosing fibroplasia
fibronectin
intestinal fibrosis
immunohistochemistry
TGF-β1
title Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
title_full Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
title_fullStr Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
title_full_unstemmed Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
title_short Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia—Extracellular Matrix Proteins and TGF-β1 Immunoexpression
title_sort feline gastrointestinal eosinophilic sclerosing fibroplasia extracellular matrix proteins and tgf β1 immunoexpression
topic collagen
feline gastrointestinal eosinophilic sclerosing fibroplasia
fibronectin
intestinal fibrosis
immunohistochemistry
TGF-β1
url https://www.mdpi.com/2306-7381/9/6/291
work_keys_str_mv AT nestorporras felinegastrointestinaleosinophilicsclerosingfibroplasiaextracellularmatrixproteinsandtgfb1immunoexpression
AT agustinrebolladamerino felinegastrointestinaleosinophilicsclerosingfibroplasiaextracellularmatrixproteinsandtgfb1immunoexpression
AT fernandorodriguezfranco felinegastrointestinaleosinophilicsclerosingfibroplasiaextracellularmatrixproteinsandtgfb1immunoexpression
AT andrescalvoibbitson felinegastrointestinaleosinophilicsclerosingfibroplasiaextracellularmatrixproteinsandtgfb1immunoexpression
AT antoniorodriguezbertos felinegastrointestinaleosinophilicsclerosingfibroplasiaextracellularmatrixproteinsandtgfb1immunoexpression